JPS6342637B2 - - Google Patents

Info

Publication number
JPS6342637B2
JPS6342637B2 JP55151609A JP15160980A JPS6342637B2 JP S6342637 B2 JPS6342637 B2 JP S6342637B2 JP 55151609 A JP55151609 A JP 55151609A JP 15160980 A JP15160980 A JP 15160980A JP S6342637 B2 JPS6342637 B2 JP S6342637B2
Authority
JP
Japan
Prior art keywords
arginyl
amino
alanyl
methyl
leucyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55151609A
Other languages
Japanese (ja)
Other versions
JPS5775956A (en
Inventor
Setsuo Fujii
Takashi Yaegashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torii Pharmaceutical Co Ltd
Original Assignee
Torii Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torii Pharmaceutical Co Ltd filed Critical Torii Pharmaceutical Co Ltd
Priority to JP55151609A priority Critical patent/JPS5775956A/en
Publication of JPS5775956A publication Critical patent/JPS5775956A/en
Publication of JPS6342637B2 publication Critical patent/JPS6342637B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Description

【発明の詳細な説明】 本発明は式()で示される新規なペプチド誘
導体及び酸付加塩に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel peptide derivatives and acid addition salts represented by formula ().

本発明化合物1は酵素に対する基質として有用
な化合物である。
Compound 1 of the present invention is a compound useful as a substrate for enzymes.

従来酵素活性の測定には種々の方法が知られて
いるが、更に高感度かつ簡便に特定の酵素の活性
を測定する方法が望まれている。
Although various methods have been known for measuring enzyme activity, there is a need for a more sensitive and convenient method for measuring the activity of a specific enzyme.

本発明物質は種々の酵素によつて加水分解され
る基質として作用し、酵素の力価、純度等の高感
度な測定に有用な物質である。
The substance of the present invention acts as a substrate that is hydrolyzed by various enzymes, and is useful for highly sensitive measurement of enzyme titer, purity, etc.

本発明のペプチド誘導体は下記のようにして製
造することができる。N〓―保護―アラニンを常
法により活性エステルとなし、これと7―アルギ
ニル―アミノ―4―メチルクマリンと反応せしめ
ることにより7―(N〓―保護―アラニル―アル
ギニル)―4―メチル―クマリンが得られる。保
護基を脱離したのち、アミノ基を保護したロイシ
ンの活性エステルを反応させることにより7―
(N〓―保護―ロイシル―アラニル―アルギニル)
―4―メチル―クマリンが得られる。同様に保護
基を脱離させると7―(ロイシル―アラニル―ア
ルギニル)―4―メチル―クマリンが得られる。
本発明のペプチド誘導体を製造する際の反応は通
常用いられる方法でよい。例えば溶媒としてはジ
メチルホルムアミド(DMF)、ジメチルスルホキ
シド(DMSO)、水、あるいはこれらの混合物の
中で行なうのがよい。
The peptide derivative of the present invention can be produced as follows. By converting N〓-protected-alanine into an active ester by a conventional method and reacting it with 7-arginyl-amino-4-methylcoumarin, 7-(N〓-protected-alanyl-arginyl)-4-methyl-coumarin is obtained. is obtained. After removing the protecting group, 7-
(N〓-protected-leucyl-alanyl-arginyl)
-4-methyl-coumarin is obtained. Similarly, when the protecting group is removed, 7-(leucyl-alanyl-arginyl)-4-methyl-coumarin is obtained.
The reaction for producing the peptide derivative of the present invention may be carried out by a commonly used method. For example, the solvent may preferably be dimethylformamide (DMF), dimethylsulfoxide (DMSO), water, or a mixture thereof.

又、アミノ基成分と反応させるカルボキシル基
成分は活性エステルとして用いるのが有利であ
り、N―ヒドロキシスクシニルイミドエステルが
好適である。反応温度は室温程度でよい。反応終
了後反応混合物を濃縮乾固し、残留物をカラムク
ロマトグラフイーにより精製し、凍結乾燥する。
ここで得られた化合物の保護基は所望により、通
常の方法で脱離することができる。例えば第三級
ブチルオキシカルボニル基はトリフロロ酢酸、又
は塩酸―ジオキサン等通常用いられるもので脱離
できる。
Further, the carboxyl group component to be reacted with the amino group component is advantageously used as an active ester, and N-hydroxysuccinylimide ester is preferred. The reaction temperature may be around room temperature. After the reaction is completed, the reaction mixture is concentrated to dryness, and the residue is purified by column chromatography and freeze-dried.
The protective group of the compound obtained here can be removed by a conventional method, if desired. For example, a tertiary butyloxycarbonyl group can be removed using commonly used agents such as trifluoroacetic acid or hydrochloric acid-dioxane.

次に本発明を例示する。 Next, the present invention will be illustrated.

例 7―L―アルギニルアミノ―4―メチルクマリ
ン塩酸塩・1/2水和物754mgをDMF25mlと水25ml
に溶解しこの中にカルボベンゾキシ―L―アラニ
ンのN―ヒドロキシスクシニルイミドエステル
833mgを加え室温で一晩撹拌したのち濃縮乾固し
た。この残留物を溶媒としてクロロホルム/メチ
ルアルコール/酢酸(95/5/3〜90/20/5)
の混合溶媒を用いてシリカゲルカラムクロマトグ
ラフイーで精製(SiO2 50g)し、目的物を含む
フラクシヨンを集め、凍結乾燥することにより7
―(N〓―カルボベンゾキシ―L―アラニル―L
―アルギニル)アミノ―4―メチルクマリン塩酸
塩900mgを得た。
Example 7-L-Arginylamino-4-methylcoumarin hydrochloride 1/2 hydrate 754 mg in DMF 25 ml and water 25 ml
N-hydroxysuccinylimide ester of carbobenzoxy-L-alanine is dissolved in
After adding 833 mg and stirring at room temperature overnight, the mixture was concentrated to dryness. Using this residue as a solvent, chloroform/methyl alcohol/acetic acid (95/5/3 to 90/20/5)
Purification was performed by silica gel column chromatography using a mixed solvent of
-(N〓-carbobenzoxy-L-alanyl-L
-Arginyl)amino-4-methylcoumarin hydrochloride (900 mg) was obtained.

融点約182℃(分解点)。Melting point: approximately 182℃ (decomposition point).

IR、3200,1715,1690,1660cm-1IR, 3200, 1715, 1690, 1660 cm -1 .

ここで得られた7―(N〓―カルボベンゾキシ
―L―アラニル―L―アルギニル)アミノ―4―
メチルクマリン塩酸塩650mgをメタノール80mlに
けんだくし、10%パラジウム炭素150mgを加え水
素ガスを3時間通導する。反応後ろ過してパラジ
ウム炭素を除き、母液を減圧濃縮し、残渣に無水
エーテルを加えることにより7―(L―アラニル
―L―アルギニル)アミノ―4―メチルクマリン
塩酸塩440mgを得た。融点約98℃(分解点)。
7-(N〓-carbobenzoxy-L-alanyl-L-arginyl)amino-4- obtained here
650 mg of methylcoumarin hydrochloride was suspended in 80 ml of methanol, 150 mg of 10% palladium on carbon was added, and hydrogen gas was passed through the mixture for 3 hours. After the reaction, palladium on carbon was removed by filtration, the mother liquor was concentrated under reduced pressure, and anhydrous ether was added to the residue to obtain 440 mg of 7-(L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride. Melting point: approximately 98℃ (decomposition point).

IR 3300,1670,1610cm-1IR 3300, 1670, 1610cm -1 .

ここで得た7―(L―アラニル―L―アルギニ
ル)アミノ―4―メチルクマリン塩酸塩400mgを
DMF20mlに溶解し、t―ブチルオキシカルボニ
ル―L―ロイシンのN―ヒドロキシスクシニルイ
ミドエステル400mgを加え、室温で一晩撹拌する。
反応液を濃縮乾固し残渣を溶媒としてクロロホル
ム/メチルアルコール/酢酸(80/20/4)の混
合溶媒を用いて、シリカゲルカラムクロマトグラ
フイーで精製(SiO2 30g)し、7―(N〓―t―
ブチルオキシカルボニル―L―ロイシル―L―ア
ラニル―L―アルギニル)アミノ―4―メチルク
マリン塩酸塩270mgを得た。
400 mg of 7-(L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride obtained here was added to
Dissolve in 20 ml of DMF, add 400 mg of N-hydroxysuccinylimide ester of t-butyloxycarbonyl-L-leucine, and stir overnight at room temperature.
The reaction solution was concentrated to dryness, and the residue was purified by silica gel column chromatography (30 g of SiO 2 ) using a mixed solvent of chloroform/methyl alcohol/acetic acid (80/20/4) as a solvent. -t-
270 mg of butyloxycarbonyl-L-leucyl-L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride was obtained.

融点約70℃(分解点)。Melting point: approximately 70℃ (decomposition point).

IR 3300,1650,1610cm-1IR 3300, 1650, 1610cm -1 .

7―(N〓―t―ブチルオキシカルボニル―L
―ロイシル―L―アラニル―L―アルギニル)ア
ミノ―4―メチルクマリン塩酸塩200mgをジオキ
サン3mlにけんだくし、9.8%塩酸―ジオキサン
溶液5.0gを加え室温で3時間30分撹拌する。反
応液にメチルアルコール5mlを加えさらに1時間
撹拌したのち、低温で溶媒を留去し、残渣に無水
エーテルを加えて析出する白色粉末、7―(L―
ロイシル―L―アラニル―L―アルギニル)アミ
ノ―4―メチルクマリン塩酸塩を集める。140mg。
7-(N〓-t-butyloxycarbonyl-L
200 mg of -leucyl-L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride is suspended in 3 ml of dioxane, 5.0 g of 9.8% hydrochloric acid-dioxane solution is added, and the mixture is stirred at room temperature for 3 hours and 30 minutes. After adding 5 ml of methyl alcohol to the reaction solution and stirring for another hour, the solvent was distilled off at a low temperature, and anhydrous ether was added to the residue to precipitate a white powder, 7-(L-
Leucyl-L-alanyl-L-arginyl)amino-4-methylcoumarin hydrochloride is collected. 140mg.

融点約116℃(分解点)。Melting point: approximately 116℃ (decomposition point).

IR 3350,1650,1615cm-1IR 3350, 1650, 1615cm -1 .

7―(t―ブチルオキシカルボニル―L―ロイ
シル―L―アラニル―L―アルギニル)アミノ―
4―メチル―クマリンを基質としたトリプシンの
活性測定法 10mM塩化カルシウムを含む50mMトリス塩酸
緩衝液(PH8.0)に7―(t―ブチルオキシカル
ボニル―L―ロイシル―L―アラニル―L―アル
ギニル)アミノ―4―メチル―クマリンを
0.1mMの濃度に溶かしたものを基質液とする。
この基質液2mlに各種濃度のトリプシン液0.1ml
を加え37℃で30分間インキユベートしたのち17%
酢酸液2mlを加える。酵素により水解されて遊離
した7―アミノ―4―メチル―クマリンを励起波
長380nm、螢光波長460nmにおける螢光強度とし
て測定する。この遊離した4―アミノ―4―メチ
ル―クマリン(AMC)が酵素の活性度に相当す
る。
7-(t-butyloxycarbonyl-L-leucyl-L-alanyl-L-arginyl)amino-
Trypsin activity measurement method using 4-methyl-coumarin as a substrate 7-(t-butyloxycarbonyl-L-leucyl-L-alanyl-L-arginyl ) Amino-4-methyl-coumarin
Use the solution dissolved to a concentration of 0.1mM as the substrate solution.
2 ml of this substrate solution and 0.1 ml of trypsin solution of various concentrations.
After adding and incubating at 37℃ for 30 minutes, 17%
Add 2 ml of acetic acid solution. The 7-amino-4-methyl-coumarin liberated by hydrolysis by the enzyme is measured as the fluorescence intensity at an excitation wavelength of 380 nm and a fluorescence wavelength of 460 nm. This released 4-amino-4-methyl-coumarin (AMC) corresponds to the activity of the enzyme.

この方法によつて測定したトリプシンの各濃度
段階における結果を図に示す。図中で縦軸は30分
間でトリプシンによつて遊離したAMCをnmole
で表わし、横軸はトリプシンをngで表わしてあ
る。
The results at each concentration level of trypsin measured by this method are shown in the figure. In the figure, the vertical axis represents nmole of AMC released by trypsin in 30 minutes.
The horizontal axis shows trypsin in ng.

【図面の簡単な説明】[Brief explanation of the drawing]

図は本発明化合物を用いた酵素の活性の測定結
果を表わす。
The figure shows the results of measuring enzyme activity using the compound of the present invention.

Claims (1)

【特許請求の範囲】 1 式() で示されるペプチド誘導体。[Claims] 1 Formula () A peptide derivative represented by
JP55151609A 1980-10-29 1980-10-29 Peptide Granted JPS5775956A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55151609A JPS5775956A (en) 1980-10-29 1980-10-29 Peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55151609A JPS5775956A (en) 1980-10-29 1980-10-29 Peptide

Publications (2)

Publication Number Publication Date
JPS5775956A JPS5775956A (en) 1982-05-12
JPS6342637B2 true JPS6342637B2 (en) 1988-08-24

Family

ID=15522267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55151609A Granted JPS5775956A (en) 1980-10-29 1980-10-29 Peptide

Country Status (1)

Country Link
JP (1) JPS5775956A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888459A1 (en) * 1996-02-02 1999-01-07 Stichting Onderzoeksbeleid Cardiopulmonale Chirurgie Measurement of complement activation by biomaterials by means of complement convertase cleavage of peptide substrates

Also Published As

Publication number Publication date
JPS5775956A (en) 1982-05-12

Similar Documents

Publication Publication Date Title
US4237047A (en) Peptide derivative
JPS6126558B2 (en)
JP3166125B2 (en) Production method of indole derivatives
JPS6342637B2 (en)
JPS6150941B2 (en)
JPS6121640B2 (en)
CA1331602C (en) Preparation process of acemetacin
JP3716376B2 (en) Optical resolving agent and method for producing optically active 3-aminopyrrolidine derivative using the same
US5977380A (en) Process for preparing N-[1- (S)-ethoxycarbonyl-3- phenylpropyl]-L-alanine derivatives
HU181503B (en) Process for producing 3,3-ethylenedioxy-4,5-seco-19-nor-androst-9-ene-5,17-dione
JPS6130559B2 (en)
JPS59112952A (en) Peptide derivative
JP2909145B2 (en) Preparation of β-lactamase inhibitors
US5003064A (en) Method for the preparation of monohydrate
JPS6338355B2 (en)
JPS626560B2 (en)
JPH0363560B2 (en)
KR930007419B1 (en) Process for preparing cephalosporin derivatives
JPS6027675B2 (en) 7-Arginylamino-4-methylcoumarin
JPS63139184A (en) Production of 6-(d(-)-alpha-(4-ethyl-2, 3-dioxopyperadine-1-ylcarbonylamino)-alpha-phenyl- acetamide)-penicillanic acid
JPS63500721A (en) New manufacturing method for chemical compounds
JPS5842862B2 (en) peptide derivative
KR100208297B1 (en) Novel process for preparing cephem derivatives
JP3005072B2 (en) Preparation of cephalosporin derivatives
JPS6337094B2 (en)